Jim Tananbaum of Foresite Capital joins Nick to discuss Growth Investing in Biotech, Genomics and Pharma. In this episode, we cover:
-His 25 years in the industry working as both an entrepreneur and investor.. often at the same time
-Jim's investment focus at Foresight
-The major changes in biotech over the past two decades
-The key elements he looks for in a business
-The main drivers causing more opportunity in the sector
-The key challenges to investing in biotech, pharma and genomics
-The role of data science in their process
-How the experience of building and IPO'ing companies has helped Jim as an investor
-How they target specific areas to invest in
-Jim's take on predatory pharmaceutical pricing
-And finally how some of these solutions might become more affordable for more people that need them